🇺🇸 SRPT — Sarepta Therapeutics, Inc.

Salud Mantener
← Volver

Precio actual

17,82 USD

Máx. histórico

178,74

2145 días

Split 1:6 del 12/07/2012

Caída desde máximo

-90,03%

Rango 52 semanas

14,68 – 24,68

Variación hoy

+1,42%

Cierre anterior

17,57

Rango de hoy

17,52 – 18,77

Volumen hoy

2.596.193

Peor caída histórica

-98,17%

09/02/2000 → 18/12/2008

Recuperado en 3568 días

Volatilidad anualizada ⓘ

95,43%

Información
Nombre completo
Sarepta Therapeutics, Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Biotechnology
Empleados
835
PER ⓘ
—
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
21,64 USD (puede no estar actualizado)
Primera cotización
04/06/1997
Precio actualizado
hace 21 horas
Sobre la empresa

Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, siRNA platform, gene therapy, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 51 skipping; VYONDYS 53 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 53 skipping; AMONDYS 45 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 45 skipping; and ELEVIDYS, an AAV-based gene therapy, which is contraindicated in patients with any deletion in exon 8 and/or exon 9 in the Duchenne gene. The company also develops SRP-9003, a gene therapy program for the treatment of LGMD2E; SRP-1001 to selectively target and knockdown DUX4 using RNAi in Phase 1/2a clinical trials; and SRP-1003 for reduction of expression of the DMPK gene in Phase 1/2a clinical trials. It has collaboration and license agreements with F. Hoffman-La Roche Ltd; Arrowhead Pharmaceuticals, Inc.; University of Western Australia; Nationwide Children's Hospital; Hansa Biopharma; and Duke University. The company was incorporated in 1980 and is headquartered in Cambridge, Massachusetts.

Splits Registrados en el histórico de precios
Fecha Ratio
12/07/2012 1:6
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
29/07/2019 149,70 150,33 146,34 148,12 -0,84% 2,67% 498.200
26/07/2019 148,69 150,57 147,41 149,37 +1,19% 2,13% 421.900
25/07/2019 149,18 149,77 146,93 147,61 -1,20% 1,90% 593.100
24/07/2019 145,91 149,67 144,97 149,40 +2,50% 3,22% 1.044.700
23/07/2019 144,76 145,94 141,43 145,76 +0,72% 3,12% 1.100.900
22/07/2019 150,50 150,62 144,43 144,72 -3,04% 4,11% 1.250.200
19/07/2019 151,94 152,09 146,33 149,26 -1,56% 3,79% 1.274.900
18/07/2019 152,89 154,70 151,15 151,63 -1,54% 2,32% 804.300
17/07/2019 153,99 156,08 153,10 154,00 +0,49% 1,94% 685.900
16/07/2019 157,33 157,33 152,15 153,25 -2,33% 3,29% 727.500
15/07/2019 157,00 158,80 155,26 156,91 +0,52% 2,25% 1.064.000
12/07/2019 154,37 156,89 152,30 156,10 +1,21% 2,97% 962.500
11/07/2019 151,91 156,00 150,42 154,24 +2,11% 3,67% 1.152.800
10/07/2019 150,79 152,46 147,92 151,05 +0,36% 3,01% 880.400
09/07/2019 149,50 151,42 147,21 150,51 +2,89% 2,82% 1.509.100
08/07/2019 149,66 150,35 143,62 146,28 -3,00% 4,50% 1.580.200
05/07/2019 150,58 153,99 149,56 150,80 -0,44% 2,94% 922.400
03/07/2019 150,09 153,66 146,14 151,47 +0,58% 5,01% 1.486.200
02/07/2019 156,97 156,97 150,25 150,59 -3,84% 4,28% 1.974.900
01/07/2019 154,50 157,28 150,00 156,60 +3,06% 4,71% 2.572.100
28/06/2019 131,10 155,75 130,09 151,95 +17,10% 19,57% 8.070.700
27/06/2019 128,76 131,65 128,55 129,76 +1,11% 2,41% 1.068.900
26/06/2019 124,89 129,43 124,62 128,34 +3,37% 3,85% 1.338.800
25/06/2019 128,55 129,95 123,79 124,16 -2,50% 4,79% 1.010.900
24/06/2019 130,23 131,00 126,45 127,34 -1,96% 3,49% 852.600
21/06/2019 129,54 130,89 127,28 129,88 -0,24% 2,79% 1.050.800
20/06/2019 135,38 135,71 129,13 130,19 -3,14% 4,86% 1.000.300
19/06/2019 133,16 135,70 132,60 134,41 +1,58% 2,33% 1.770.100
18/06/2019 128,97 134,00 128,00 132,32 +4,13% 4,65% 2.042.200
17/06/2019 121,35 127,99 120,06 127,07 +6,27% 6,53% 1.595.900